In this study, the results of NC009-1 to down-regulate NLRP3 and IL-1β in MPP+-treated HMC3 microglia and MPTP-treated mice highlight its potential to reduce PD neuroinflammation and neurodegeneration. Here, NLRP3 is linked to Parkinson disease.